Characteristics of Patients With Neovascular Age-related Macular Degeneration Enrolled in the Brolucizumab Patient Support Services Program

NCT05066685 · clinicaltrials.gov ↗

COMPLETED

Status

18457

Enrollment

INDUSTRY

Sponsor class

Conditions

Age-related Macular Degeneration (AMD)

Interventions

OTHER: All participants

Sponsor

Novartis Pharmaceuticals